Position in NGNE
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$4,620,162
+$1,228,888 QoQ
Shares Held
146,905
-12.7% QoQ
Ownership
0.734%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#22
of 111 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 74%
Shared 0%
None 26%
Common Shares in NGNE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BLAIR WILLIAM & CO/IL holds $157,670,224 across 60 Biotechnology names. NGNE ranks #8 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
513,573 | $36,283,932 | |
| 2 | ARGX |
Argenx SE
|
27,666 | $25,667,684 | |
| 3 | VKTX |
Viking Therapeutics, Inc.
|
416,766 | $16,258,041 | |
| 4 | EXEL |
Exelixis, Inc.
|
243,215 | $13,233,328 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
18,400 | $9,139,832 | |
| 6 | SLDB |
Solid Biosciences Inc.
|
756,277 | $7,555,207 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
23,450 | $5,739,856 | |
| 8 | NGNE |
Neurogene Inc.
This page
|
146,905 | $4,620,162 |
All Filings in NGNE
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,620,162 | 146,905 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $3,391,274 | 168,218 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $3,371,293 | 163,655 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,457,740 | 141,820 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,991,878 | 133,236 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $1,770,317 | 151,180 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $1,431,950 | 62,640 | Shares | Sole | 2025-02-12 | |
| No filing history on record for this holder in this stock. | ||||||